20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Fasudil Hydrochloride for Pulmonary Arterial Hypertension (PAH) Research

Pulmonary Arterial Hypertension (PAH) is a severe and progressive condition characterized by high blood pressure in the arteries of the lungs, leading to right heart failure and reduced quality of life. Fasudil Hydrochloride, a potent Rho-associated protein kinase (ROCK) inhibitor, is being actively investigated for its therapeutic potential in managing PAH.

The pathophysiology of PAH involves excessive proliferation and migration of pulmonary artery smooth muscle cells, leading to vasoconstriction and vascular remodeling. Fasudil Hydrochloride, by inhibiting the RhoA/Rho kinase pathway, can counteract these processes. Its vasodilatory effects specifically on the pulmonary vasculature offer a promising avenue for reducing pulmonary artery pressure and improving blood flow to the lungs.

By relaxing the constricted pulmonary arteries, Fasudil Hydrochloride can alleviate the workload on the right ventricle, thereby potentially improving symptoms and slowing disease progression. Its mechanism of action complements existing PAH therapies and may offer a novel approach for patients who do not respond adequately to current treatments.

For researchers and pharmaceutical developers focused on PAH, obtaining high-quality Fasudil Hydrochloride is crucial for conducting robust studies. When you intend to buy Fasudil Hydrochloride, selecting a reliable manufacturer and supplier is essential to ensure product purity and consistency. As a leading Fasudil Hydrochloride supplier in China, we are committed to providing researchers with the high-grade compound they need for their critical investigations. We offer competitive pricing and can provide a comprehensive quote upon request.

The investigation into Fasudil Hydrochloride's efficacy in PAH treatment represents a significant step forward in finding new therapeutic solutions for this challenging disease. If your research involves pulmonary hypertension, we encourage you to partner with us, a trusted manufacturer, to access this important research compound.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Future of Ophthalmic Drug Development with Fasudil Hydrochloride

Next: Sourcing High-Purity Lidocaine HCl Powder: A Guide for Procurement Managers

All Rights Reserved